|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6960 EUR | +1.75% |
|
-17.24% | +326.06% |
| 16/07 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 16/07 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
Quotes 5-day view: Valerio Therapeutics
Delayed Quote Deutsche Boerse AG
| 03/08/2026 | 04/08/2026 | 05/08/2026 | 06/08/2026 | 07/08/2026 | |
|---|---|---|---|---|---|
| Last | €0.7500 | €0.7010 | €0.6960 | €0.6840 | €0.6050 |
| Volume | 8,000 | 0 | 0 | 0 | 0 |
| Change | +2.60% | -6.53% | -0.71% | -1.72% | +1.75% |
| Opening | €0.7260 | €0.7290 | €0.6960 | €0.6840 | €0.6050 |
| High | €0.7500 | €0.7290 | €0.6960 | €0.6840 | €0.6050 |
| Low | €0.7260 | €0.7010 | €0.6960 | €0.6840 | €0.6050 |
Performance
| 1 day | +1.75% | ||
| 1 week | -17.24% | ||
| Current month | -17.24% | ||
| 1 month | +45.78% | ||
| 3 months | +303.33% | ||
| 6 months | +343.22% | ||
| Current year | +326.06% | ||
| 1 year | +839.44% | ||
| 3 years | +175.00% | ||
| 5 years | +4.85% | ||
| 10 years | -80.70% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
30,96,57,946
Market Cap (USD)
35,68,31,005
Net sales ()
25,73,000
Net sales (USD)
29,64,969
Number of employees
25
Sales / Employee (EUR)
1,02,920
Sales / Employee (USD)
1,18,599
Free-Float
64.77 %
Free-Float capitalization (EUR)
20,05,73,412
Free-Float capitalization (USD)
23,11,28,614
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
0.7124
Moving average 20 days
0.6608
Moving average 50 days
0.395
Moving average 100 days
0.2707
Price spread / (MMA5)
+2.36%
Price spread / (MMA20)
-5.06%
Price spread / (MMA50)
-43.25%
Price spread / (MMA100)
-61.11%
RSI 9 days
52.6
RSI 14 days
56.87
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.75% | -17.24% | +839.44% | +175.00% | 36Cr | |
| -0.37% | +3.59% | +85.69% | +162.07% | 1,06200Cr | |
| +0.20% | +0.19% | +49.73% | +48.37% | 62TCr | |
| +0.40% | -2.65% | +22.84% | +62.50% | 43TCr | |
| +1.44% | +4.67% | +48.57% | +39.74% | 36TCr | |
| +0.88% | -0.25% | +35.71% | +40.55% | 29TCr | |
| +0.57% | -5.60% | +8.90% | +9.54% | 25TCr | |
| +0.34% | +5.42% | +42.62% | +60.52% | 22TCr | |
| +4.46% | -0.13% | -0.89% | -43.91% | 20TCr | |
| +1.87% | +2.00% | +20.43% | +64.63% | 16TCr | |
| Average | +1.16% | -1.90% | +115.31% | +61.90% | 35.93TCr | |
| Weighted average by Cap. | +0.59% | -0.83% | +48.57% | +75.87% |
Historical Quotes: Valerio Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.6 |  | 0.75 |
| 1 month | 0.38 | | 0.93 |
| Current year | 0.09 | | 0.93 |
| 1 year | 0.04 | | 0.93 |
| 3 years | 0.03 | | 0.93 |
| 5 years | 0.03 | | 0.93 |
| 10 years | 0.03 | | 5.38 |
Monthly variations
Annual variations
| 2026 | +381.69% | ||
| 2025 | +71.29% | ||
| 2024 | -45.28% | ||
| 2023 | +25.21% | ||
| 2022 | -70.34% | ||
| 2021 | -38.55% | ||
| 2020 | +29.43% | ||
| 2019 | -39.36% | ||
| 2018 | -20.93% | ||
| 2017 | -56.66% | ||
| 2016 | -32.71% | ||
| 2015 | -29.50% | ||
| 2014 | +22.30% | ||
| 2013 | -9.31% | ||
| 2012 | +47.83% | ||
| 2011 | -41.33% | ||
| 2010 | +17.61% | ||
| 2009 | +108.14% | ||
| 2008 | -83.38% | ||
| 2007 | +18.01% | ||
| 2006 | -14.36% | ||
| 2005 | -1.79% |
- Stock Market
- Stocks
- ALVIO Stock
- C4X Stock
- Quotes Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions
